This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lukacs, N. W. Articles by Peebles, R. S. Search for Related Content PubMed PubMed Citation Articles by Lukacs, N. W. Articles by Peebles, R. S., Jr

(American Journal of Pathology. 2006;169:977-986.)
© 2006 American Society for Investigative Pathology
DOI: 10.2353/ajpath.2006.051055

Differential Immune Responses and Pulmonary Pathophysiology Are Induced by Two Different Strains of Respiratory Syncytial Virus

Nicholas W. Lukacs^*, Martin L. Moore, Brian D. Rudd^*, Aaron A. Berlin^*, Robert D. Collins, Sandra J. Olson, Samuel B. Ho and R. Stokes Peebles, Jr

From the Department of Pathology,^* University of Michigan Medical School, Ann Arbor, Michigan; the Departments of Medicine and Pathology, Vanderbilt University School of Medicine, Nashville, Tennessee; and the Veterans Affairs Medical Center, University of Minnesota, Minneapolis, Minnesota

In this study we performed comparisons of pulmonary responses between two different respiratory syncytial virus (RSV) antigenic subgroup A strains, A2 and Line 19. Line 19 strain induced significant dose-responsive airway hyperreactivity (AHR) in BALB/c mice at days 6 and 9 after infection, whereas the A2 strain induced no AHR at any dose. Histological examination indicated that A2 induced no goblet cell hyper/metaplasia, whereas the Line 19 induced goblet cell expansion and significant increases in gob5 and MUC5AC mRNA and protein levels in vivo. When examining cytokine responses, A2 strain induced significant interleukin (IL)-10 expression, whereas Line 19 strain induced significant IL-13 expression. When IL-13^–/– mice were infected with Line 19 RSV, the AHR responses were abrogated along with gob5 gene expression. There was little difference in viral titer throughout the infection between the line 19- and A2-infected mice. However, the A2 strain grew to significantly higher titers than the Line 19 strain in HEp-2 cells in vitro. Thus, RSV Line 19-induced airway dysfunction does not correlate with viral load in vivo. These data demonstrate that different RSV strains of the same antigenic subgroup can elicit differential immune responses that impact the phenotypic expression of RSV-induced illness.

This article has been cited by other articles:

				P. L. Collins and B. S. Graham Viral and Host Factors in Human Respiratory Syncytial Virus Pathogenesis J. Virol., March 1, 2008; 82(5): 2040 - 2055. [Full Text] [PDF]

				E. M. Castilow, D. K. Meyerholz, and S. M. Varga IL-13 Is Required for Eosinophil Entry into the Lung during Respiratory Syncytial Virus Vaccine-Enhanced Disease J. Immunol., February 15, 2008; 180(4): 2376 - 2384. [Abstract] [Full Text] [PDF]

				J. J. Smit, L. Boon, and N. W. Lukacs Respiratory Virus-Induced Regulation of Asthma-Like Responses in Mice Depends upon CD8 T Cells and Interferon-{gamma} Production Am. J. Pathol., December 1, 2007; 171(6): 1944 - 1951. [Abstract] [Full Text] [PDF]

				M. A. Schaller, R. Neupane, B. D. Rudd, S. L. Kunkel, L. E. Kallal, P. Lincoln, J. B. Lowe, Y. Man, and N. W. Lukacs Notch ligand Delta-like 4 regulates disease pathogenesis during respiratory viral infections by modulating Th2 cytokines J. Exp. Med., November 26, 2007; 204(12): 2925 - 2934. [Abstract] [Full Text] [PDF]

				M. M. Monick, L. S. Powers, I. Hassan, D. Groskreutz, T. O. Yarovinsky, C. W. Barrett, E. M. Castilow, D. Tifrea, S. M. Varga, and G. W. Hunninghake Respiratory Syncytial Virus Synergizes with Th2 Cytokines to Induce Optimal Levels of TARC/CCL17 J. Immunol., August 1, 2007; 179(3): 1648 - 1658. [Abstract] [Full Text] [PDF]